Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| Reliance Pharma Fund - Direct Plan Growth Plan - Growth Option | 155.9 | -2.45% | -2.76% | -5.50% | 7.65% | 11.38% | 13.25% | 2019-02-22 |
| Reliance Pharma Fund-Growth Plan-Growth Option | 148.2 | -2.53% | -2.98% | -5.94% | 6.72% | 9.41% | 10.25% | 2019-02-22 |
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 8.9 | -3.99% | -4.91% | -9.54% | -0.56% | -2.62% | -9.08% | 2019-02-22 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 8.4 | -4.20% | -5.39% | -10.41% | -2.43% | -6.02% | -13.80% | 2019-02-22 |
| UTI Pharma & Healthcare Fund-Growth Option- Direct | 86.7 | -3.35% | -2.96% | -10.37% | -4.06% | -5.55% | -4.33% | 2019-02-22 |
| UTI Pharma & Healthcare Fund-Income Option-Direct | 67.0 | -3.35% | -2.97% | -10.38% | -4.07% | -5.54% | -4.33% | 2019-02-22 |
| UTI Pharma & Healthcare Fund-Growth Option | 82.0 | -3.43% | -3.22% | -10.86% | -5.07% | -7.43% | -7.06% | 2019-02-22 |
| UTI Pharma & Healthcare Fund-Income Option | 63.4 | -3.44% | -3.22% | -10.87% | -5.08% | -7.44% | -7.07% | 2019-02-22 |
| SBI PHARMA - DIRECT PLAN -GROWTH | 122.1 | -5.95% | -5.69% | -10.33% | -6.08% | -14.16% | -11.59% | 2019-02-22 |
| SBI PHARMA - REGULAR PLAN -GROWTH | 114.1 | -6.00% | -5.90% | -10.80% | -7.20% | -16.19% | -14.74% | 2019-02-22 |
